Continuous bioprocessing methodologies present a myriad of benefits over their batch processing counterparts. The key difference between batch and continuous bioprocessing lies in the seamlessness of the production process. In the case of batch processing, production typically stops following the completion of each step of the drug's manufacturing process. The hallmark of continuous processing, on the other hand, is a seamless production cycle without interruptions after each step of the production process. Rapidly changing market demands are forcing companies to adapt and streamline their manufacturing processes; hence, the need for manufacturing innovations such as continuous bioprocessing.

What Is Covered:

  • Primer on the Differences Between Conventional Batch and Continuous Bioprocessing Methods
  • Why Hybrid Systems are an Attractive Alternative from End-to-End Continuous Models
  • Where Single-Use Technologies Fit Into the Equation 
  • What the Near Future Holds for the Industry